Summary Notification Information Format (SNIF) for MVA-NSmut

Year: 2014

Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut

Summary Notification Information Format (SNIF) AdCh3NSmut1

Year: 2014

Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine AdCh3NSmut1

Equilis RhodE Trial - Final Report

Year: 2014

Final report on the Equilis RhodE veterinary trial

Intervet Letter of 10 March 2014 re cessation of trial

Year: 2014

Correspondence received from Intervet International B.V. on 10 March 2014 to advise the Agency of their decision to stop the veterinary trial

G0493-01 Inspector's Report to the Board of the Agency

Year: 2013

All documentation submitted in respect of this notification, including valid representations made by members of the public, was taken into consideration by the EPA Inspector in her report to the Board of the Agency.

Inspector's Memo to Board for approval to modify condition

Year: 2013

Inspector's Memo to Board for approval to modify condition

Letter from EPA to Intervet International BV with modified condition

Year: 2013

Letter from EPA to Intervet International BV, dated 11 June 2013, with modified condition

How to make a representation for G0493-01

Year: 2013

How to make a representation to the EPA about the proposed Deliberate Release G0493

Board Minute Extract re decision on modified condition

Year: 2013

An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8

G0493-01 Valid representations received from members of the public

Representations received from members of the public in response to Intervet International BV's notification, June 2013

Year: 2013

The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine

Non-confidential Annex List G0493

Year: 2013

List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493

G0493-01 Consent Conditions

Year: 2013

G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine

Board minute extract for Agency Board Meeting of 9 April 2013

Year: 2013

An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.

GM equine vaccine Equilis RhodE application

Year: 2013

Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine

Requests for further information, and responses received

Year: 2013

Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.

GMO Register G0498-01

Year: 2013

The GMO Register entry provides significant details of the clinical trial

Environmental Risk Assessment Dossier

Year: 2013

Environmental Risk Assessment Dossier for Clinical Trial G0498-01

Requests for further information and replies

Year: 2013

Requests from the Agency to the notifier for additional information, and the responses received.

Technical Dossier Non-Confidential

Year: 2013

Environmental Risk Assessment Dossier (in accordance with Schedule II, SI 500 of 2003) for proposed Clinical Trial G0498-01

Part D Conclusions G0498-01

Year: 2013

Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01

Pagination